Drug and Device Clinical Trial Institution
Beijing Huaxin Hospital completed registration as a medical device clinical trial institution in March 2019 and as a drug clinical trial institution in December 2023.
Medical Device Clinical Trial Registration
Registered departments: 18
Registered specialties: 29, including:
1.Internal Medicine: Respiratory Medicine, Gastroenterology, Cardiovascular Medicine, Nephrology, Endocrinology, Geriatrics.
Surgery: Orthopedics, Urology, Thoracic Surgery, Cardiovascular Surgery.
2.Other Specialties: Dermatology (Plastic Surgery, Dermatology, Medical Cosmetology), Pediatrics (Neonatology, Pediatric Endocrinology), Ophthalmology , Anesthesiology , Laboratory Medicine (Clinical Hematology, Clinical Microbiology, Clinical Chemistry, Clinical Immunology and Serology, Clinical Cytogenetics and Molecular Genetics), Transfusion Medicine, Medical Imaging (X-ray, CT, MRI, Nuclear Medicine, Interventional Radiology), Pharmacy (Pharmaceutical Sciences).
The institution can undertake clinical trials of Class I to Class III medical devices within the registered specialties, except for the six special product categories listed in the Catalogue of Class III Medical Devices Requiring Clinical Trial Approval (2020).
Drug Clinical Trial Registration
Registered specialties: Gastroenterology, Neurology, and Endocrinology.
The institution is qualified to conduct Phase I–IV drug clinical trials within these specialties.
For clinical trials related to the registration and approval of drugs or medical devices, please contact our Clinical Trial Office.
Contact: Jiao Wang: hxyyjgb@163.com
Core Website：http://www.tufh.com.cn/Html/News/Articles/11796.html?WebVisitShield=wifvokN8y8CgGXFsChLW
Copyright © 2024 Tsinghua Medicine,Tsinghua University All Rights Reserved.
Research Updates